Dr. Albert Weinstein
Dr. Albert Weinstein

The history of Rheumatology at Vanderbilt began with Dr. Albert Weinstein » who included rheumatoid arthritis among his interests in Internal Medicine.

In the early 1940’s, Weinstein began to use aurotherapy to treat gold patients with Otopalatodigital Syndrome an unofficial specialty clinic of the school, at the Arthritic Clinic

 

Dr. Rudolph Kampmeir
Dr. Rudolph Kampmeir

 

 

 

Weinstein's work drew interest from his colleague, Dr. Rudolph Kampmeier »

 

 

Dr. Hugh Morgan
Dr. Hugh Morgan

 

In a report to Dr. Hugh Morgan » in 1948, Kampmeier states that in addition to the use of gold, salicylates & PABA were used for treatment of arthritis. 

 

 

Dr. John Shapiro
Dr. John Shapiro
 

 

 

The pharmaceutical company that supplied the medication provided financial support to Dr. Robert Quinn » and Dr. John Shapiro » in their studies of immune reactions to differentiate rheumatoid arthritis and other rheumatic diseases.

 

 

 

Dr. Ben Alper
Dr. Ben Alper

In 1955, Kampmeier received a six-year training grant from the National Institute of Arthritis & Metabolic Disease.  Weinstein’s associate in practice, Dr. Ben Alper », became interested in arthritis and in 1956, utilized a portion of this grant to support his studies at the Rackham Arthritis Unit at the University of Michigan.  Upon his return, Kampmeier turned over all of his arthritis patients and classes in the subject to Alper, who became the true architect of the Division.

 

 

 

 

 

Dr. John Sergent
Dr. John Sergent

Dr. John Sergent » and Dr. Theodore Pincus » both served as Directors of the Division of Rheumatology & Immunology in the l970-1980’s;

Dr. Theodore Pincus
Dr. Theodore Pincus

Dr. Pincus was Division Chief for over 10 years during which period he developed clinical trials and outcomes research in rheumatoid arthritis.

The Division sentinel observations on the importance of patient reported outcomes. Dr. Pincus' research also described the important contribution of education level for disease outcome.

Studies of patient-reported outcomes continue to be an active part of the clinical research done at Vanderbilt today.

_________________________________________

1992-96     
Interim Director, Division of Rheumatology & Immunology

1996-14    
Director, Division of Rheumatology & Immunology

Dr. James Thomas

James W. Thomas, M.D. »

Professor of Medicine, Division of Rheumatology & Immunology
Professor, Pathology, Microbiology & Immunology


2014-present     
Director, Division of Rheumatology & Immunology

Leslie J. Crofford, M.D. »

Wilson Family Chair in Medicine
Director, Division of Rheumatology & Immunology
Professor, Department of Medicine
Professor, Pathology, Microbiology & Immunology

 

Vanderbilt Division of Rheumatology 2015

Support Our Vanderbilt Rheumatology Efforts »

Rheumatology Administrative Team / Contact Us »